Lower drug clearance of adalimumab is associated with proactive therapeutic drug monitoring and mucosal healing in patients with inflammatory bowel disease.
Deyhim, Tina, Alessandra Saraga, Ajay Gade, Grace Geeganage, Mostafa A Soliman, Samantha Zullow, Loren G Rabinowitz, et al. 2026. “Lower Drug Clearance of Adalimumab Is Associated With Proactive Therapeutic Drug Monitoring and Mucosal Healing in Patients With Inflammatory Bowel Disease.”. European Journal of Gastroenterology & Hepatology.